Optina Diagnostics
1 known investors
Optina develops a retinal imaging and AI platform for diagnosing and managing Age-Related Macular Degeneration in eye care specialists and patients. The platform combines hyperspectral imaging technology with AI clinical decision support to improve early detection and disease monitoring.
Investors · 1
Competitors · 2
by search overlapOptain Health4 shared keywordsHealthcare technology company using robotic retinal imaging, AI and teleophthalmology to screen for eye and systemic disease.
Cognoptix3 shared keywordsCognoptix develops the Sapphire II system, a non-invasive laser eye scanning device paired with an eye ointment that binds to beta amyloid proteins in the lens of the eye to aid early detection and diagnosis of Alzheimer's disease. The company builds diagnostic devices and agents for clinical, commercial, and academic research use and works with pharma partners and academic institutes.
Companies competing with Optina Diagnostics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Optina Diagnostics do?
- Optina develops a retinal imaging and AI platform for diagnosing and managing Age-Related Macular Degeneration in eye care specialists and patients. The platform combines hyperspectral imaging technology with AI clinical decision support to improve early detection and disease monitoring.
- Who are Optina Diagnostics's investors?
- Optina Diagnostics's investors include DigitalDx Ventures.